Form 4 Tracker
Hims & Hers Health, Inc.
HIMS

92 insider filings · Latest: Oct 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 3, 2025Mar 3 4:59 PMBecklund Irene
Proposed Sale
2,913$45.14$131.5K—

View →

Mar 3, 2025Mar 3 4:45 PMBoughton Soleil
Proposed Sale
4,151$45.14$187.4K—

View →

Feb 24, 2025Feb 24 3:46 PMChi Michael
Proposed Sale
17,303$48.14$833.0K—

View →

Feb 19, 2025Feb 19 3:16 PMChi Michael
Proposed Sale
7,500$59.26$444.4K—

View →

Feb 18, 2025Feb 18 4:22 PMBoughton Soleil
Proposed Sale
4,152$60.69$252.0K—

View →

Feb 18, 2025Feb 18 4:10 PMDudum Andrew
Proposed Sale
175,661$58.24$10.2M—

View →

Feb 12, 2025Feb 12 9:36 PMMelissa Baird
Proposed Sale
67,687$46.34$3.1M—

View →

Feb 10, 2025Feb 10 5:09 PMChi Michael
Proposed Sale
7,259$43.28$314.2K—

View →

Feb 3, 2025Feb 3 4:11 PMBoughton Soleil
Proposed Sale
4,153$35.30$146.6K—

View →

Feb 3, 2025Feb 3 4:11 PMChi Michael
Proposed Sale
2,054$35.30$72.5K—

View →

Jan 31, 2025Jan 31 3:43 PMDudum Andrew
Proposed Sale
100,000$35.22$3.5M—

View →

Jan 24, 2025Jan 24 2:53 PMChi Michael
Proposed Sale
17,304$31.00$536.4K—

View →

Jan 23, 2025Jan 23 5:55 PMDudum Andrew
Proposed Sale
27,098$30.08$815.0K—

View →

Jan 22, 2025Jan 22 9:24 PMDudum Andrew
Proposed Sale
14,269$30.08$429.2K—

View →

Jan 21, 2025Jan 21 9:55 PMMelissa Baird
Proposed Sale
67,687$29.81$2.0M—

View →

Jan 21, 2025Jan 21 9:54 PMDudum Andrew
Proposed Sale
300$30.00$9.0K—

View →

Jan 21, 2025Jan 21 9:32 PMBoughton Soleil
Proposed Sale
54,153$29.90$1.6M—

View →

Jan 21, 2025Jan 21 3:16 PMChi Michael
Proposed Sale
306$28.68$8.8K—

View →

Jan 16, 2025Jan 16 5:40 PMDudum Andrew
Proposed Sale
83,994$27.04$2.3M—

View →

Jan 10, 2025Jan 10 3:39 PMChi Michael
Proposed Sale
7,259$24.07$174.7K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 22, 2026Sep 23 8:17 PMOluyemi OkupeChief Financial Officer
Option Exercise
14,000$5.0166,872(D)

View →

Aug 19, 2026Aug 20 8:30 PMOluyemi OkupeChief Financial Officer
Option Exercise
4,938$5.0180,872(D)

View →

Aug 14, 2026Aug 18 9:04 PMSoleil BoughtonChief Legal Officer
Option Exercise
42,261—164,598(D)

View →

Aug 14, 2026Aug 18 9:04 PMKare SchultzDirector
Option Exercise
6,623—6,624(D)

View →

Aug 14, 2026Aug 18 9:04 PMPatrick Harrison CarrollChief Medical Officer
Option Exercise
26,187—131,678(D)

View →

Aug 14, 2026Aug 18 9:04 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Option Exercise
154,993—362,114(D)

View →

Aug 14, 2026Aug 18 9:04 PMMichael ChiChief Operating Officer
Option Exercise
86,265—329,194(D)

View →

Aug 17, 2026Aug 18 9:04 PMOluyemi OkupeChief Financial Officer
Option Exercise
9,388$5.0185,810(D)

View →

Aug 14, 2026Aug 18 9:04 PMOluyemi OkupeChief Financial Officer
Option Exercise
71,616—263,356(D)

View →

Aug 14, 2026Aug 18 9:04 PMDeborah M. AutorDirector, Chief Policy Officer
Option Exercise
32,920—427,953(D)

View →

Aug 14, 2026Aug 18 9:03 PMDavid B WellsDirector
Option Exercise
778—0(D)

View →

Aug 14, 2026Aug 18 9:03 PMMohamed ElshenawyCTO
Option Exercise
188,285—1,100,000(D)

View →

Aug 14, 2026Aug 18 9:03 PMIrene BecklundPAO
Option Exercise
13,685—54,317(D)

View →

Aug 14, 2026Aug 18 9:03 PMChristopher D PayneDirector
Option Exercise
545—0(D)

View →

Aug 12, 2026Aug 14 8:16 PMMohamed ElshenawyCTO
Grant/Award
1,200,000—1,200,000(D)

View →

Aug 12, 2026Aug 14 8:16 PMKare SchultzDirector
Grant/Award
8,223—8,223(D)

View →

Aug 12, 2026Aug 14 8:16 PMChristopher D PayneDirector
Grant/Award
8,768—545(D)

View →

Aug 12, 2026Aug 14 8:15 PMGarcia Andrea G PerezDirector
Grant/Award
8,223—8,223(D)

View →

Aug 12, 2026Aug 14 8:15 PMAnja ManuelDirector
Grant/Award
8,223—8,223(D)

View →

Aug 12, 2026Aug 14 8:15 PMDelos M. CosgroveDirector
Grant/Award
8,223—8,223(D)

View →

Page 1 of 4

Next →